Table 3.
Additional value of DATA2 (intention-to-treat analysis).
| DATA1 | DATA2 | p | OR | ||
|---|---|---|---|---|---|
| Total | Rm | 52% [38–66%] (n = 25) | 77% [65–89%] (n = 37) | 4 × 10 −5 | 5.2 |
| (n = 48) | Rs | 65% [51–78%] (n = 31) | 88% [78–97%] (n = 42) | 2 × 10 −6 | 5 |
| MAOI first | Rm | 45% [29–61%] (n = 17) | 76% [63–90%] (n = 29) | 5 × 10 −6 | 6.8 |
| (n = 38) | Rs | 66% [51–81%] (n = 25) | 84% [73–96%] (n = 32) | 0.0018 | 3.9 |
| D2RAG first | Rm | 60% [30–90%] (n = 6) | 80% [55–100%] (n = 8) | 0.11 | 4.2 |
| (n = 10) | Rs |
p-values of χ2-tests. Rm, remitters; Rs, responders. The p-values are in bold when the difference is significant (α = 0.05, bilateral, uncorrected for multiple testing), and in gray italic when not significant. Odds ratios (OR) show that adding MAOI to D2RAG is similar in magnitude to adding D2RAG to MAOI.